Catalyst Wire Dossier Catalyst Wire Dossier

Onkovis Irinotecan

Irinotecan · Onkovis GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Onkovis Irinotecan, covering 2018-05-23 to 2018-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

See pricing